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A potential cytosolic metallocarboxypeptidase from Burk-
holderia cenocepacia has been crystallized and a synchrotron-
radiation microfocus beamline allowed the acquisition of
diffraction data to 1.9 A˚ resolution. The asymmetric unit
comprises a tetramer containing over 1500 amino acids, and
the high-throughput automated protocols embedded in
PDB_REDO were coupled with model–map inspections in
refinement. This approach has highlighted the value of such
protocols for efficient analyses. The subunit is constructed
from two domains. The N-terminal domain has previously only
been observed in cytosolic carboxypeptidase (CCP) proteins.
The C-terminal domain, which carries the Zn2+-containing
active site, serves to classify this protein as a member of the
M14D subfamily of carboxypeptidases. Although eukaryotic
CCPs possess deglutamylase activity and are implicated in
processing modified tubulin, the function and substrates of the
bacterial family members remain unknown. The B. cenoce-
pacia protein did not display deglutamylase activity towards
a furylacryloyl glutamate derivative, a potential substrate.
Residues previously shown to coordinate the divalent cation
and that contribute to peptide-bond cleavage in related
enzymes such as bovine carboxypeptidase are conserved. The
location of a conserved basic patch in the active site adjacent
to the catalytic Zn2+, where an acetate ion is identified,
suggests recognition of the carboxy-terminus in a similar
fashion to other carboxypeptidases. However, there are
significant differences that indicate the recognition of
substrates with different properties. Of note is the presence
of a lysine in the S10 recognition subsite that suggests
specificity towards an acidic substrate.
Received 15 March 2013
Accepted 30 September 2013
PDB reference:
carboxypeptidase, 4b6z
1. Introduction
Carboxypeptidases (CPs) hydrolyse peptide bonds in target
proteins to release C-terminal amino acids. These enzymes
have been classified into different families according to
sequence similarity, mechanism and function (Gomis-Ru¨th,
2008; Rawlings et al., 2012). One of the largest groups, carrying
a single catalytic Zn2+ in the active site, is the M14 family. This
is divided into four subfamilies known as M14A, M14B,
M14C and M14D. One of the earliest and best studied family
members is bovine carboxypeptidase A (CP-A; Christianson
& Lipscomb, 1989). In general, M14A and M14B carboxy-
peptidases either function within the secretory pathway or are
themselves secreted. The members of the M14A subfamily are
produced as pro-enzymes that are activated following the
cleavage of N-terminal segments. The M14B subfamily are
produced as active enzymes with a transthyretin-like domain
at the C-terminus. The M14C group consists of bacterial
enzymes related to -d-glutamyl-(l)-meso-diaminopimelate
peptidase I (http://merops.sanger.ac.uk/) and process compo-
nents of the bacterial cell wall. Like their M14A relatives, they
also carry an N-terminal extension.
The M14D subfamily has only recently been described and
consequently there is only limited information regarding their
structure and activity. They are referred to as cytosolic
carboxypeptidases (CCPs; http://merops.sanger.ac.uk/) to
reflect their cellular location. A search of available genomic
data identified CCPs in many organisms (Otero et al., 2012)
and the number of CCP paralogues varies between species
(Rodriguez de la Vega et al., 2007). Four mammalian CCP
proteins and a homologue from Caenorhabditis elegans called
CeCCPP-6 have been identified as deglutamylases (Kimura et
al., 2010; Rogowski et al., 2010). In addition to this activity,
CCPs might process other C-terminal amino acids. For
example, one member of the family has recently been reported
to cleave the C-terminal tyrosine from -tubulin (Sahab et al.,
2010). Less is known about the functional activity of the
bacterial CCPs. A recent study of Pseudomonas aeruginosa
CCP (PaCCP) failed to detect any activity towards known CP
substrates, and the possibility has been raised that structural
changes might be required to generate an active enzyme
(Otero et al., 2012).
Our interest in the bacterial homologues is twofold. It has
proven difficult to obtain a recombinant source of mammalian
CCP for characterization and therefore the prokaryotic
proteins offer a surrogate system to inform on the post-
translational modification of tubulin. We also note that in the
important Gram-negative pathogen P. aeruginosa the gene
encoding the CCP homologue (PA2831) has been identified as
essential for the establishment of a lung infection in a murine
model (Winstanley et al., 2009), and as such the CCP might
represent a potential drug target for an important group of
Gram-negative bacteria. As part of a wide-ranging project
to advance early-stage drug discovery of novel antibacterials,
we have adopted a structure-based approach to drive target
assessment (Eadsforth et al., 2012; Moynie et al., 2013). Key to
this process is to acquire material for ligand-binding studies:
an accurate structural model which can be exploited to inform
on aspects of druggability and crystals that might assist in
fragment screening (Hunter, 2009). We initiated work on
P. aeruginosa CCP (PaCCP; UniProt entry Q9I012) and
on Burkholderia cenocepacia CCP (BcCCP; UniProt entry
B4EEQ5). We made no progress with PaCCP, but a study has
been published by others (Otero et al., 2012). Our work with
BcCCP was more successful and here we report the prepara-
tion of an efficient recombinant protein-production system
and protocols for purification and crystallization together with
the high-resolution structure. With only small crystals avail-
able, it was necessary to exploit a microfocus beamline to
obtain the diffraction data. BcCCP consists of 384 amino acids
and forms a tetramer. The asymmetric unit comprises four
subunits comprising in excess of 1500 amino acids. With a
sizable model and high-resolution diffraction data with which
to refine it, we sought an efficient route through the refine-
ment process and incorporated the strategies employed in
the PDB_REDO protocols (Joosten et al., 2011, 2012). We
compare BcCCP with PaCCP (Otero et al., 2012), with two
other bacterial CCP structures in the Protein Data Bank
(PDB) and with mammalian carboxypeptidases of defined
substrate specificity. These structures identify the key residues
and motifs that are important for the stability of the CCP fold
and the architecture of the catalytic centre, reveal the
presence of a flexible loop at the periphery of the active site
and suggest that the substrate of the bacterial proteins is
acidic. Moreover, they support a druggability analysis of the
active site.
2. Materials and methods
2.1. Reagents, preparation of a recombinant expression
system and protein purification
Chemicals and materials were sourced from Sigma–Aldrich
and VWR International, except where stated otherwise.
Genomic DNA from B. cenocepacia J2315 [Laboratory for
Microbiology, Faculty of Sciences, Ghent University (LMG)
strain 16656] was the template for PCR with the following
primers designed to amplify the BcCCP open reading frame
using NdeI and XhoI restriction sites (bold), respectively:
50-CAT-ATG-ACC-CTT-TCG-ATC-ACC-AG-30 and 50-CTC-
GAG-TTA-CGC-GAA-CGT-GTC-30. The PCR product was
ligated into pCR-Blunt II-TOPO (Invitrogen) prior to being
subcloned into a modified pET-15b vector (Novagen), which
produces a histidine-tagged protein with a Tobacco etch virus
(TEV) protease site. The hexa-His tag, TEV cleavage site and
additional residues from the choice of cloning sites added a
total of 24 extra amino acids at the N-terminus. The recom-
binant plasmid was amplified in Escherichia coli XL-1 Blue
cells and the integrity of the gene sequence was verified by
DNA Sequencing & Services (Dundee University) before
being transformed into E. coli ArcticExpress (DE3) compe-
tent cells for protein production. Cells were grown in 1 l
Luria–Bertani medium supplemented with 50 mg ml1 carbe-
nicillin. Gene expression was induced at 310 K using 1 mM
isopropyl -d-1-thiogalactopyranoside and growth continued
for 72 h at 286 K.
The cells were harvested by centrifugation (30 min at 3500g
and 277 K), resuspended in lysis buffer (50 mM Tris–HCl pH
7.5, 250 mM NaCl) containing DNase I (0.1 mg) and a single
tablet of a cocktail of EDTA-free protease inhibitors (Roche)
and lysed using a French press at 110 MPa. Insoluble debris
was separated by centrifugation at 37 500g for 30 min at 277 K.
The soluble fraction was loaded onto a 5 ml HisTrap HP
column (GE Healthcare) and a linear imidazole concentration
gradient was applied to elute BcCCP. Fractions were analyzed
using SDS–PAGE and those containing BcCCP were pooled.
The hexa-His tag could not be cleaved, so protein still carrying
the affinity tag was further purified using a Superdex 200 26/60
size-exclusion column (GE Healthcare) equilibrated with
50 mM Tris–HCl, 250 mM NaCl pH 7.5. This column had
previously been calibrated using the molecular-mass standards
thyroglobulin (670 kDa), -globulin (158 kDa), ovalbumin
(44 kDa), myoglobin (17 kDa) and vitamin B12 (1.35 kDa)
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(Bio-Rad; Fig. 1). Selected fractions were pooled, dialyzed
into 100 mM sodium acetate, 150 mM NaCl pH 5 and
concentrated to 10 mg ml1 using Amicon Ultra devices
(Millipore). The protein concentration was determined spec-
trophotometrically using a theoretical extinction coefficient
of 73 590M1 cm1 at 280 nm calculated using ProtParam
(Gasteiger et al., 2005). The sample purity was verified by
matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry and SDS–PAGE (data not shown), with typical
protein yields in excess of 20 mg per litre of culture. Native
PAGE and size-exclusion chromatography with multi-angle
light scattering (SEC–MALS) were used to establish the
oligomeric state of the protein. SEC–MALS experiments were
performed on a Dionex Ultimate 3000 HPLC system with an
inline Wyatt miniDAWN TREOS multi-angle light-scattering
detector and an Optilab T-rEX refractive-index detector.
SEC–MALS analysis was performed on an Superdex 200 10/
300 column (GE Healthcare) equilibrated with 50 mM Tris–
HCl, 250 mM NaCl pH 7.5. Molar masses spanning the elution
peaks were calculated with ASTRA v.6.0.0.108 (Wyatt).
2.2. Crystallization and data collection
Crystallization trials were carried out with a Phoenix
liquid-handling system (Art Robbins Instruments/Rigaku)
and commercially available screens (Hampton Research).
100 nl protein solution (10 mg ml1 in 100 mM sodium acetate
pH 5.0, 150 mMNaCl, 0.5 mM ZnSO4) was mixed in a 1:1 ratio
with reservoir solution and equilibrated against 70 ml reservoir
solution at 293 K. Orthorhombic rod-shaped crystals of
approximately 30 10 10 mm in size were observed after 3 d
using a reservoir consisting of 0.2M Li2SO4, 25% PEG 3350,
0.1M bis-tris pH 5.5. A single crystal was transferred into a
cryosolution consisting of the original reservoir supplemented
with 20% glycerol prior to flash-cooling at 100 K and was then
characterized in-house using a MicroMax-007 rotating-anode
generator and an R-AXIS IV++ dual image-plate detector
(Rigaku) prior to storage in liquid nitrogen. X-ray diffraction
data extending to 1.9 A˚ resolution were subsequently
collected on the ID23-2 microfocus beamline at the European
Synchrotron Radiation Facility (ESRF). Owing to the size of
the crystal and its particularly long c axis, it was necessary to
utilize a microfocus beam of approximately 10 mm and a
helical data-collection strategy. Such a data-collection strategy,
combined with a short exposure time of 0.6 s and a MAR
Research Mosaic 225 charge-coupled device detector, allowed
good separation of the reflections, appropriate sensitivity and
low X-ray damage, allowing a complete data set to be
collected. Integration and scaling of the data were carried out
using MOSFLM (Leslie, 2006) and SCALA (Evans, 2006).
The space groupwasP212121, with unit-cell parameters a= 62.9,
b = 85.9, c = 289.0 A˚. The asymmetric unit consists of four
subunits each of mass 45.3 kDa, with approximately 1500
residues in total, a VM value of 2.17 A˚
3 Da1 and a solvent
content of approximately 45%.
2.3. Structure solution and refinement
The structure was solved by molecular replacement using a
polyalanine model of the monomer of a CCP structure from
B. mallei (BmCCP), which shares 85% sequence identity
(PDB entry 3k2k; Joint Center for Structural Genomics,
unpublished work). The rotation and translation functions in
Phaser (McCoy et al., 2007) revealed the positions of four
polypeptide chains with a log-likelihood
gain of 6469. Inspection of the mole-
cular packing in Coot (Emsley et al.,
2010) showed no steric clashes and
suggested that a tetramer, consistent
with the SEC–MALS results (discussed
below), was present. Rigid-body refine-
ment was carried out in REFMAC5
(Murshudov et al., 2011). The resolution
range was set from 144.5 to 2.5 A˚ and
the Rfree value was 33.3% following
rigid-body refinement. Ten cycles of
restrained refinement were then carried
out with the resolution extended to
1.9 A˚. The Rwork and Rfree values were
24.6 and 28.6%, respectively. Chain A
was inspected with electron-density and
difference density maps in Coot and
some missing side chains were added,
while those out of density were deleted.
Chain A was rotated and translated to
provide the other three chains in the
asymmetric unit and the four Zn2+ ions
were included. The model was subjected
to several cycles of PDB_REDO
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Figure 1
Investigating the quaternary structure of BcCCP. A gel-filtration chromatogram for BcCCP is
displayed on the left. The protein eluted with an apparent molecular mass of 140 kDa as calculated
from a previously determined calibration curve. Native PAGE analysis of purified BcCCP is shown
on the right. The 4–16% native PAGE (Novex) gel shows protein (lane 1) and molecular-mass
standards (lane 2; labelled in kDa).
refinement (Joosten et al., 2012) followed by electron-density
and difference density map inspection, rebuilding and inclu-
sion of water molecules and ligands. Translation/libration/
screw analysis (TLS; Painter & Merritt, 2006) was applied to
create different group descriptions.
The PDB_REDO process consisted of the following steps.
(i) The B factor was reset to the Wilson B followed by ten
cycles of TLS refinement using one TLS group per chain. (ii)
Seven ten-cycle trial refinements were performed keeping the
TLS model established in (i) fixed, using automatic geometric
restraint weighting from REFMAC5 and trying increasingly
loose B-factor restraint weights. The optimal weight was 0.30,
which is lower than the default. (ii) Six 30-cycle refinements
were performed using the fixed TLS model, the optimized
B-factor restraint weight and increasingly tight geometric
restraint weights. A restraint weight of 0.10 gave the best
refinement results. Details of the selection algorithm are
presented in Joosten et al. (2012). (iv) Model rebuilding
consisting of water deletion, peptide flipping, side-chain
rotamer searching and His/Asn/Gln flipping was performed to
improve hydrogen bonding (Joosten et al., 2011). (v) A final
refinement consisting of five cycles of TLS refinement starting
from the previously refined model, followed by ten cycles of
restrained refinement using a B-factor weight of 0.30 and
trying three different geometric restraint weights (0.05, 0.10
and 0.15) was performed. Refinement with a slightly looser
geometric restraint weight than before (0.15) gave the best
results.
A further round of map inspections, model fitting and
PDB_REDO refinement was carried out. The output model
was again inspected with the relevant maps and adjusted,
further waters were added and multiple conformers were now
included at several positions. Further restrained refinement
followed, using the B-factor and geometric weights established
with PDB_REDO and a TLS description comprising 12
groups in total. Local noncrystallographic symmetry (NCS)
restraints were imposed at the onset of the refinement and
were maintained until the final round of calculations. The
crystallographic statistics and model geometry are shown in
Table 1. Coordinates and structure factors have been depos-
ited in the PDB with accession code 4b6z. The model
geometry was monitored with MolProbity (Chen et al., 2010).
Structure superpositions were calculated using Secondary
Structure Matching (Krissinel & Henrick, 2004) in Coot (using
LSQKAB; Kabsch, 1976), and the Protein Interfaces, Surfaces
and Assemblies (PISA) server (Krissinel & Henrick, 2007)
was used to characterize the protein–protein oligomerization
interface. Amino-acid sequence alignments were performed
with Clustal Omega (Sievers et al., 2011). Active-site volumes
were calculated using ICM PocketFinder (MolSoft Limited).
Secondary structure was assigned using Coot and by inspec-
tion. Figures were prepared using PyMOL (DeLano, 2002)
and ALINE (Bond & Schu¨ttelkopf, 2009).
3. Results and discussion
3.1. General comments
Size-exclusion chromatography was used as the final puri-
fication step and the protein eluted as a single species with a
mass of approximately 140 kDa; a native PAGE gel showed
a band of around 146 kDa (Fig. 1). The theoretical mass of
BcCCP is approximately 45.3 kDa; these data were therefore
taken to infer the presence of an oligomer, but it was unclear
what the quaternary structure was. However, SEC–MALS
shows that the protein elutes with a mass of 174 kDa (Fig. 2)
corresponding to a tetramer, and this is consistent with the
assembly observed in the crystal structures of BcCCP (the
subunits are labelled A–D; Figs. 3 and 4), BmCCP and the
protein from Shewanella denitrificans (SdCCP; PDB entry
3l2n; Joint Center for Structural Genomics, unpublished
work). This is distinct from PaCCP, which was reported to
behave as a monomer in solution (Otero et al., 2012). The
tetramer has a gap or hole at the centre of the assembly and
this may have influenced the elution properties, whereas the
research papers
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Table 1
Crystallographic statistics.
Values in parentheses are for the highest resolution shell.
Space group P212121
Unit-cell parameters (A˚) a = 62.90, b = 85.95, c = 289.02
Resolution (A˚) 40–1.90 (2.00–1.90)
No. of reflections recorded 516512 (74589)
Unique reflections 124234 (17924)
Completeness (%) 99.9 (100.0)
Multiplicity 4.2 (4.2)
hI/(I)i 8.4 (2.7)
Wilson B (A˚2) 13.3
Radiation source and beamline ID23-2, ESRF
Wavelength (A˚) 0.873
Residues
Subunit A 2–156, 159–383
Subunit B 2–318, 320–384
Subunit C 2–156, 159–314, 320–384
Subunit D 1–315, 320–384
No. of waters 1062
No. of glycerol molecules 9
No. of ethylene glycol molecules 7
No. of PEG molecules 1
No. of Cl ions 3
No. of Zn2+ ions 4
No. of acetate ions 4
Rmerge† (%) 13.0 (48.4)
Rwork‡/Rfree§ (%) 16.4/20.5
Mean B factors (A˚2)
Subunits A, B, C, D 6.7
Ligands and waters 26.2
Cruickshank DPI} (A˚) 0.13
Ramachandran plot††
Most favoured (%) 96.9
Additional allowed (%) 2.9
Outliers (%) 0.2
Deviations from ideal values‡‡
R.m.s.d., bond lengths (A˚) 0.01
R.m.s.Z, bond lengths 0.56
R.m.s.d., bond angles () 1.14
R.m.s.Z, bond angles 0.62
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the intensity of
the ith measurement of reflection hkl and hI(hkl)i is the mean value of Ii(hkl) for all i
measurements. ‡ Rwork =
P
hkl

jFobsj  jFcalcj

=
P
hkl jFobsj, where Fobs is the observed
structure factor and Fcalc is the calculated structure factor. § Rfree is the same as Rwork
except calculated with a subset (5%) of data that were excluded from refinement
calculations. } Diffraction-component precision index (Cruickshank, 1999). †† Chen
et al. (2010). ‡‡ Engh & Huber (1991).
use of light scattering offers a better approximation of the
assembly size.
Diffraction data were acquired by exploiting the use of a
microfocus synchrotron-radiation beamline to accommodate
the small size of the crystal and to help circumvent the issue
of a long unit-cell edge. The structure was solved by molecular
replacement and, in order to carry out the efficient refinement
of a relatively large asymmetric unit with over 1500 residues
and data to high resolution, we adopted a slightly unconven-
tional route by using PDB_REDO. This procedure uses a
variety of automated protocols to test different models for B
factors using weighting restraints on geometry, optimization
with respect to diffraction data terms and side-chain
rebuilding, for example (Joosten et al., 2012). The approach
has been developed to efficiently apply modern refinement
techniques to update and improve the contents of the PDB.
It has been our experience that the majority of structures that
we have inspected have been improved in terms of agreement
with the diffraction data and in many cases in chemical
correctness. The approach worked well in this refinement and
we suggest that the lessons encapsulated in PDB_REDO have
much to offer especially if incorporated early in the refine-
ment process. We suggest that near the end of the refinement
and building process, when interactive rebuilding is limited to
the final polishing of the model, it is no longer advantageous to
perform subsequent PDB_REDO runs. Instead, the optimized
refinement settings from the last PDB_REDO run can be used
in REFMAC5 directly. To this end, PDB_REDO has been
updated to provide a keyword file for REFMAC5 that can be
research papers
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Figure 3
The tetramer of BcCCP. The protein is displayed as a semi-transparent
van der Waals surface over the ribbon cartoon. Subunits are labelled A
(yellow), B (green), C (cyan) and D (blue). Asterisks mark the positions
of disordered loops.
Figure 2
SEC–MALS analysis of BcCCP. The horizontal blue line corresponds to
the calculated mass of BcCCP, which was determined to be 174 kDa. The
theoretical mass of a monomer is 45.3 kDa; thus SEC–MALS indicates
the presence of a tetramer.
Figure 4
The interfaces between subunits A and B (a) and subunits A and C (b) in
the tetramer. The secondary-structure elements which contain residues
contributing to tetramer formation are labelled. The N- and C-termini are
labelled and the disordered loops are marked with asterisks. The dashed
line points to the N-terminal end, which is located at the back and is not
visible in the cartoon.
used in the CCP4 graphical user interface (Winn et al., 2011) to
quickly import these settings.
Continuous well defined electron density is observed for
most of the structure. The only disordered regions include the
N- and C-terminal residues, residues 157–158 in chains A and
C and a number of residues in a loop (315–320) in subunits B,
C and D. Superposition of C positions of all four chains gives
root-mean-squared deviations (r.m.s.d.s) in the range 0.23–
0.35 A˚, indicating that the subunits are, within the errors
associated with the structure, essentially identical. Note that
the diffraction-component precision indicator (Cruickshank,
1999) was calculated to be 0.13 A˚. We therefore detail only
subunit A unless stated otherwise.
A strong feature in electron-density and difference density
maps was observed in each active site near Arg226. These
were modelled as acetates derived from the 50 mM sodium
acetate present in the crystallization conditions. In the crystal
structure of PaCCP complexed with guanidinoethylmercapto-
succinic acid (Otero et al., 2012; PDB entry 4a39) and in the
structure of CP-A with benzylsuccinic acid (Christianson &
Lipscomb, 1986; Mangani et al., 1992; PDB code 1cbx) the
carboxyl groups of the ligands are located at the same position
as this acetate (data not shown).
3.2. Subunit structure and comparison with other CCPs
The structure of BcCCP consists of two domains, a common
feature of M14 family members. The primary, secondary and
tertiary structures are presented in Fig. 5. Residues Met1–
Glu112 form the N-terminal domain, while the remaining 272
residues make up the CP domain. The N-terminal domain
folds into a nine-stranded antiparallel -sandwich. Strands 2,
3, 5, 8 and 7 form one sheet and strands 1, 4, 9 and 6
form the other. This domain is specific to CCP proteins and is
absent in other carboxypeptidases. It has been hypothesized
that the N-terminal domain might contribute to folding, might
have a regulatory function and/or might be involved in binding
other proteins (Kalinina et al., 2007; Rodriguez de la Vega et
al., 2007). A comparison of the structure of the N-terminal
domains of BcCCP and PaCCP gave an r.m.s.d of 0.87 A˚ over
109 C positions, indicating close simi-
larity.
The CP domain of BcCCP displays a
similar topology of secondary-structure
elements, an // sandwich structure
with a seven-stranded antiparallel -
sheet, as observed in other M14 family
carboxypeptidases, for example bovine
carboxypeptidase A (CP-A; Fig. 6). A
superposition of BcCCP and bovine
CP-A (Kim & Lipscomb, 1990; PDB
entry 6cpa), which share about 20%
sequence identity, gives an r.m.s.d of
2.03 A˚ for 225 C positions. The cores of
the structures fit well (Fig. 6), but on the
periphery of the active site there are
large differences that will be described
later. Overlay of the CP domain of
BcCCP with those of BmCCP (PDB
code 3k2k), SdCCP (PDB entry 3l2n)
and PaCCP (PDB entry 4a39; Otero et
al., 2012) reveals a higher degree of
conservation, with r.m.s.d values of
0.45 A˚ (374 C atoms), 0.85 A˚ (362 C
atoms) and 1.07 A˚ (365 C atoms),
respectively. These proteins share about
85, 50 and 40% sequence identity with
BcCCP, respectively, and the degree of
structural similarity correlates well with
the level of sequence conservation.
BcCCP contains several motifs which
are conserved in CCP family proteins.
One of them, Asn216-Pro217-Asp218-
Gly219, occurs between 13 and 4,
with the proline at the start of the helix
(Fig. 5b). This motif contributes to
domain folding and the formation of
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Figure 5
(a) The secondary and tertiary structure of BcCCP. A ribbon diagram of subunit A showing
-helices coloured magenta and -strands coloured orange, with Zn2+ depicted as a grey sphere. The
N- and C-terminal positions are labelled, as are the -helices and -strands. A small section of a
loop (residues 157 and 158, marked with black asterisks), as well as the first and last residues at the
N- and C-termini, are absent from the model owing to disorder. (b) The primary and secondary
structure of BcCCP. Residues that are strictly or highly conserved in BcCCP, BmCCP, SdCCP,
PaCCP and CeCCPP-6 are shown on black and grey backgrounds, respectively. Three residues that
coordinate Zn2+ are marked with yellow stars. The three motifs of the N-terminal domain which are
conserved in CCP members are enclosed by green boxes.
part of the active site (Fig. 7). On one side of the motif Asp218
establishes hydrogen bonds to the side chains of Thr140 and
Arg144 and to the main-chain amide of Glu142. These inter-
actions serve to link 13 to 10 and 11, which are on the
surface of the domain. On the other side of the motif
Asn216 O1 accepts a hydrogen bond from the amide of
Gly219 to hold the side chain in place and N2 is a donor in
hydrogen-bond formation to the main-chain carbonyl of
Gln170 in 12, thus linking different elements of secondary
structure together. The side chain of Gln170 also participates
in four hydrogen bonds that link 12 to 14 and the segment
between 4 and 5. The -strand link (not shown) involves the
donation of a hydrogen bond from Gln170 N"2 to Asp266 O2.
The other three hydrogen bonds, to the carbonyl of Leu234
and the side chains of Asn235 and Trp238, help to position 12
and the interhelical segment. The positioning of 12 and 14
contributes to the formation of the active site because they
provide His171 and His268, respectively, to coordinate the
catalytic Zn2+.
Mammalian CCP proteins are considerably larger than their
bacterial homologues, with N- and C-terminal extensions plus
numerous insertions. The sequences of the extended regions
vary and their function is at present not known. However, all
CCP members share three short sequence motifs within the
N-terminal domain which are
absent in other CP families
(Kalinina et al., 2007). These
conserved motifs are located in
close proximity, even though they
are distant in the primary amino-
acid sequence (Figs. 5b and 8).
Motif I, F(D,E)xGx(L,I), residues
9–14, links 1 with 2 and extends
to form part of the second strand.
Motif II, W(F,Y)(Y,N)(F,Y), resi-
dues 40–43, forms a major part of
4, a buried strand, and with the
sequence Trp-Phe-Tyr-Tyr contri-
butes significantly to the forma-
tion of the hydrophobic core of
the domain together with other
aromatic residues such as Phe9,
Phe57, Trp69, Trp83, Tyr110 and
Phe111 (data not shown). Resi-
dues 113–115, P(F,Y)(S,T), form
motif III at the N-terminus of 1
on the surface of the domain. This
segment forms part of the inter-
face between the N-terminal and
CP domains and contributes to
interactions with the partner
subunits in the dimers (A–B and
C–D) forming a tetramer. It is
noteworthy that these motifs and
features are conserved in the
PaCCP, BmCCP and SdCCP
structures (Fig. 5b), and this
observation supports the idea that
together they are important for
the correct folding of the domain
and its position with respect to the
CP domain.
3.3. Quaternary structure
BcCCP forms a tetramer
arranged as a dimer of dimers
(A–B and C–D in Fig. 3). The
N-terminus of each BcCCP
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Figure 7
The conserved Asn-Pro-Asp-Gly motif. The left panel shows the residues in stick representation and
selected hydrogen-bonding interactions as dashed black lines. The Asn-Pro-Asp-Gly residues are shown in
cyan. The right panel shows a ribbon diagram of a subunit to indicate the position of this motif with respect
to the overall fold.
Figure 6
Stereoview C trace showing the superposition of BcCCP (black) with bovine CP-A (red; PDB entry 6cpa).
The 6–7 loop of BcCCP is drawn in cyan. The active-site Zn2+ is shown as a grey sphere and a loop that
remains disordered in BcCCP is marked with two asterisks.
subunit is located close to the CP domain of the dimer partner
(Fig. 4a). This might explain why the N-terminal hexa-His tag
could not be cleaved with TEV protease. The average solvent-
accessible surface area of the four subunits in the asymmetric
unit is approximately 15 500 A˚2. The total solvent-accessible
area of the BcCCP tetramer is 52 600 A˚2, with a buried area of
9400 A˚2. The interface formed between two BcCCP dimers
(A–B and C–D) occludes 2800 A˚2, while the interface between
subunits A–C and B–D equates to 1900 A˚2. Therefore, about
9% of the surface area of each subunit is involved in dimer
formation, with a further 6% involved in associations to
assemble a tetramer. The free energy of dissociation is esti-
mated to be 14.9 kcal mol1, suggesting that the tetrameric
assembly is thermodynamically stable. These values correlate
well with those calculated for tetrameric BmCCP and SdCCP
proteins. For example, the total surface areas of the BmCCP
and SdCCP structures are 52 500 and 49 900 A˚2, with buried
areas of 11 900 and 9600 A˚2, respectively. The secondary-
structure elements forming the interface within a BcCCP
tetramer are shown in Figs. 4(a) and 4(b). Individual BcCCP
dimers are stabilized by around 24 hydrogen bonds, nine salt
bridges and van der Waals interactions. Some of the residues
contributing to dimer formation include Gln127 and Glu117 in
1, Asp104 in a loop between 8 and 9, Ser105 in 9, Arg80
in a loop between 6 and 7, Glu142 in a loop between 10
and 11, Val134 in 10 and Asn8 in 1. We note eight
hydrogen bonds and two salt bridges between a pair of dimers
in a tetramer. A few of the residues involved in these inter-
actions include Asp193 in a loop between 2 and 3, Lys186 in
2, Arg201 in 3 and Pro354 in a loop between 16 and 8.
These residues are not conserved in PaCCP, which is a
monomer in solution. However, these residues are well
conserved in BmCCP and SdCCP, in which similar subunit–
subunit associations are noted in tetramer formation (data not
shown).
3.4. The active site and specificity
The active site of BcCCP is an elongated cavity with a base
formed by residues in 14, 15 and 16, walls formed by loops
linking 4–5, 6–7, 3–4 and 5–6 and then the 14–15
turn (Figs. 5 and 9). Here, the catalytic Zn2+ is coordinated by
two histidines (His171 and His268), Glu174 in a chelating 2
interaction and a water molecule to give a pentacoordinated
distorted tetrahedral geometry (Fig. 10). The active-site cleft
is occupied by an acetate derived from the crystallization
conditions. This anion, which marks the binding site for the
substrate carboxylate, is held in place by electrostatic inter-
actions with Arg226, Asn235 and Arg236 (Fig. 10).
The bacterial CCP active sites, and in particular the metal-
ion environment (Fig. 11), display a high degree of structural
conservation and this even extends to bovine CP-A, although
here the overall sequence identity is only about 20% (see
x3.2). The His171 and Glu174 residues occur in a His-Pro-Gly-
Glu motif which is highly conserved in CCP proteins (Fig. 5b).
In BcCCP and BmCCP a buried Arg169 side chain is posi-
tioned by a salt bridge to Glu178 and a hydrogen bond to the
carbonyl of Tyr114, and in turn helps to stabilize the confor-
mation of the His-Pro-Gly-Glu motif by making a hydrogen
bond to the main-chain carbonyl of Pro172 (data not shown).
In the other known structures different residues occupy the
space near the motif and fulfil the role of stabilizing part of the
metal ion-binding site. In bovine CP-A Phe116 provides steric
bulk and Gln76 provides the hydrogen bond to the active-site
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Figure 8
Three motifs common to the CCP family: motif I (marine), motif II
(orange) and motif III (purple). The active-site Zn2+ is shown as a grey
sphere and the three conserved motifs of the N-terminal domain that are
found in all M14D family members are shown in marine and are labelled
accordingly.
Figure 9
The active-site cavity of BcCCP. The protein is depicted as a semi-
transparent van der Waals surface over the ribbon cartoon. The surface is
coloured according to atom type: C, white; O, red; N, blue. Zn2+ is shown
as a grey sphere. Key contributors to the formation of the active site and
the S10 pocket are labelled.
proline to position this metal-binding motif (Christianson &
Lipscomb, 1989).
A proposed mechanism for bovine CP-A involves the
activation of a water molecule by the divalent cation assisted
by Glu270 acting as a general base and interacting directly
with substrate. This supports the generation of a potent
nucleophile (Christianson & Lipscomb, 1989). Arg127 helps to
stabilize an oxyanion hole by binding to the substrate carbonyl
(Kim & Lipscomb, 1990). These key residues are conserved
as Arg226 and Glu344 in BcCCP (Fig. 11). Other residues
conserved in the active site throughout the M14 family include
Asn144 and Arg145 of bovine CP-A, which bind to the
C-terminal carboxylate of the substrate. In BcCCP they are
conserved as Asn235 and Arg236.
Whilst most of the CCP polypeptide chains overlay well, as
described, there is a noteworthy exception, part of the flexible
6–7 loop along one side of the active site, which displays
different conformations (Fig. 6). Similar observations about
flexibility and different configurations of this part of the active
site have been made when comparing bovine and rat
carboxypeptidase structures (Faming et al., 1991).
The inherent flexibility of this loop is indicated by the
thermal parameters. In BcCCP the thermal parameters for the
C atoms in this section, residues His313–Tyr320, average at
27.4 A˚2 compared with an overall average of 6.7 A˚2 for all
protein atoms. The structural difference is best exemplified by
comparing the positions of Lys319 and Tyr320 of the two most
conserved structures, BcCCP and BmCCP (Fig. 12). The
BcCCP structure displays an open configuration and the
BmCCP structure a closed configuration with Tyr320 directed
into the active site. The C positions of this pair of residues
differ by just over 7 A˚.
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Figure 10
The active site and Zn2+ coordination in BcCCP. Selected residues in the
active site and acetate are displayed and coloured as follows: C, white
(yellow for acetate); O, red; N, blue. The 2Fo  Fc electron-density map is
shown for acetate, where Fo represents the observed structure factors and
Fc represents the calculated structure factors. The map is depicted at the
1 level (cyan chicken wire). The cation and a water ligand are shown as
spheres coloured grey and marine, respectively. Zinc coordination is
shown by black continuous lines; blue dashed lines represent hydrogen-
bonding interactions.
Figure 11
A comparison of the BcCCP and bovine CP-A active sites. The
coordinates of CP-A were those of PDB entry 6cpa and the figure is
based on the superposition shown in Fig. 2. Residue side chains are
depicted as sticks with atomic positions coloured red for O, blue for N and
green for C for bovine CP-A or all in cyan for BcCCP. The C atom of
Gly253 of CP-A is shown as a small black sphere. The catalytic cations are
shown as overlapping grey spheres.
Figure 12
The flexible 6–7 loop. The BcCCP and BmCCP (PDB entry 3k2k)
subunit structures are overlaid and the C trace for residues 315–326 is
shown in green and blue, respectively. The side chains of Lys319 and
Tyr320 are shown as sticks.
An overlay of BmCCP (PDB entry 3k2k) and CP-A (PDB
entry 1cbx), both displaying the closed configuration, places
the hydroxyl groups of Tyr320 and Tyr248 within 1 A˚ of each
other (data not shown). In BcCCP Tyr320 is directed out and
away from the active site and a major conformational change
of about 17 A˚ would be required to place the hydroxyl in the
active site in a similar position to that of Tyr248 in CP-A. In
CP-A the tyrosine adopts an outward configuration in the
absence of ligand but swings in when a ligand, for example
glycyl-tyrosine, is present. Site-directed mutagenesis suggests
that it is not a critical determinant of the carboxypeptidase
reactivity since kcat is unaffected for small substrates.
However, a significant increase in Km indicates a role in ligand
binding, so this tyrosine and the pliable loop in which it resides
may assist in the recognition and binding of protein substrates
(Gardell et al., 1985). Subsequent mutagenesis studies led to
the proposal that the tyrosine hydroxyl contributes to the
mechanism by helping to activate the catalytic Zn2+-bound
water (Cho et al., 2001). We cannot find any structural data to
support such a conclusion since the functional group on the
tyrosine side chain is too distant to make a hydrogen bond to
the catalytic water that is bound to Zn2+ and there is already a
glutamate contributing such a function. Rather, we agree with
Gardell et al. (1985) that this tyrosine is well positioned to bind
substrates and to assist in fulfilling the hydrogen-bonding
capacity of substrates, intermediates or products during the
catalytic cycle. There is another tyrosine, Tyr315, positioned
in the active site a little closer to the catalytic Zn2+ and the
associated water molecule. This then provides a tyrosine pair
that might contribute to substrate placement in BcCCP.
The substrate specificities of bovine CP-A and rat CP-A2
are well understood (Faming et al., 1991) and structural
differences between CP-A and BcCCP suggest that these
enzymes have distinctive specificities. Firstly, it is worth noting
that we are comparing a ligand complex of CP-A with unli-
ganded BcCCP. This is relevant in that the 6–7 loop displays
a closed configuration in CP-A, positioned over the active site.
The residues in these loops placed in the vicinity of the active
site might interact with substrates, but the key determinants of
specificity reside in the side-chain binding pocket, the S10 site
itself (Figs. 9, 10 and 11), and are strongly influenced by only
a few residues. In CP-A these are Ile243, Asn144, Ala250,
Gly253, Ile255, Asp256 and Thr268. Ile243 and Ala250,
together with Tyr248, are in the 6–7 loop capping the S10
pocket. Asn144 and Thr268 are conserved as Asn235 and
Thr342 in BcCCP part-way down to the bottom of the S10 site.
Ile255 in CP-A corresponds to Ser329 in BcCCP and the
hydroxyl group makes the bottom of the S10 subsite polar.
Nearby, two differences, Gly253 and Asp256 in CP-A but
Leu327 and Lys330 in BcCCP, make the the S10 subsite much
more shallow in the bacterial enzyme and replace an acidic
residue with a basic one (Fig. 10). In bovine CP-A Asp256
directly interacts with a side chain of substrate (Christianson
& Lipscomb, 1986) and by providing an acidic hydrogen-bond
accepting capability helps to define the specificity of the
enzyme. The side chain of Lys330 in BcCCP extends into the
space occupied by Ile243 and Asp256 in CP-A (data not
shown). Lys330 of BcCCP is strictly conserved in BmCCP and
therefore the S10 subsite in the Burkholderia enzymes is
perfectly matched to bind glutamic acid, consistent with the
putative function as a polyglutamylase. The lysine is replaced
by an asparagine (Asn321) in both SdCCP and PaCCP, so the
S10 subsite would still be cabable of binding glutamate.
To test BcCCP for deglutamylase activity, in vitro assays
were performed using a furylacryloyl glutamate derivative
(data not shown). Only low levels of this substrate were
cleaved, indicating that BcCCP might not be a deglutamylase,
that the tested ‘substrate’ is not appropriate or that the
enzyme might require activation, as is the case for bovine
CP-A.
3.5. Issues regarding druggability
The concept of a druggable protein concerns the properties
of a binding site on the target to bind molecules that possess
the right physicochemical attributes to make them bioavail-
able and have a high affinity for the target and a low toxicity
to humans (Hunter, 2009; Fauman et al., 2011). The optimal
target would be a small, well defined and ordered cavity in the
protein with pronounced hydrophobic components, although
there are notable exceptions. The active sites of enzymes such
as pteridine reductase (PDB entry 2x9g; Dawson et al., 2010)
and dihydrofolate reductase (PDB entry 3cl9; Schormann et
al., 2008) would be described as ‘druggable’. The volumes of
their active sites are estimated as 350 and 380 A˚3, respectively.
Based on the crystal structures of the proteins discussed here
the substrate-binding cavity of bacterial CCP is estimated to
occupy a volume of approximately 310–410 A˚3, which would
be judged of a sufficient size to bind drug-like molecules (An
et al., 2005).
Although size matters, the chemical properties of the active
site are also critical. In this respect, we note specific functional
groups (e.g Lys330) and hydrophobic surfaces (tyrosines) that
might interact with potential inhibitors. There is, in addition,
the presence of the catalytic Zn2+ that provides opportunities
to incorporate metal-ion affinity into inhibitory molecules.
4. Concluding remarks
The structure of BcCCP has been determined. Only small
crystals with a relatively long unit-cell c parameter of about
290 A˚ could be obtained. However, by exploiting the advan-
tages of a microfocus synchrotron beamline we were able to
obtain high-resolution diffraction data. An unconventional
approach to refinement was adopted by exploiting the
strengths inherent in the automated protocols of
PDB_REDO. This ensured efficient refinement of an asym-
metric unit containing over 1500 residues and a large number
of water molecules. Our experience was positive and points to
a future in which such an approach might become standard.
The structure is compared with those of other CCP proteins
and with that of CP-A. The CP domain of BcCCP is similar to
other M14 family CPs, while the N-terminal domain assembles
into a fold unique to CCP subfamily proteins. Our data
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provide details of the active site and reveal the spatial
conformation of residues involved in Zn2+ coordination and
reaction catalysis. Specific differences localized to the S10
pocket on one side of the active site suggest that the bacterial
CCP proteins process substrates based on the recognition of
an acidic residue. This would be commensurate with their
assignment as polyglutamylases, although further experiments
are required to address this issue.
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